TY  - GEN
AU  - Sculier,J P
AU  - Lafitte,J J
AU  - Paesmans,M
AU  - Thiriaux,J
AU  - Alexopoulos,C G
AU  - Baumöhl,J
AU  - Schmerber,J
AU  - Koumakis,G
AU  - Florin,M C
AU  - Zacharias,C
AU  - Berghmans,T
AU  - Mommen,P
AU  - Ninane,V
AU  - Klastersky,J
TI  - Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
SN  - 0007-0920
PY  - 2000///1207
KW  - Adult
KW  - Aged
KW  - Alopecia
KW  - chemically induced
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Ifosfamide
KW  - Leukopenia
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mitomycin
KW  - Multivariate Analysis
KW  - Neoplasm Staging
KW  - Survival Analysis
KW  - Survival Rate
KW  - Thrombocytopenia
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1054/bjoc.2000.1413
ER  -